Franklin Resources
DICE icon

Franklin Resources’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Franklin Resources’s Portfolio DICE Stock Details DICE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-336,358
Closed -$9.6M – 2786
2023
Q1 		$9.6M Hold
336,358
– – ﹤0.01% 937
2022
Q4 		$10.5M Buy
+336,358
New +$11M 0.01% 934

Other funds holding DICE

RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Avoro Capital Advisors
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Alpine Associates Management
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
Driehaus Capital Management
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Magnetar Financial
Magnetar Financial Evanston, Illinois $10.2B AUM 0.67% 1-Year Est. Return
Pentwater Capital Management
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
UBS O'Connor
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

Franklin Resources's DICE Position: Q2 2023 in Review

Franklin Resources sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q2 2023, closing a stake of 336,358 shares — an estimated $9.6M sold.

Franklin Resources first reported a position in DICE in Q4 2022 and held it in 2 quarters. The position peaked at $10.5M in Q4 2022. 160 funds tracked by Wall St. Rank hold DICE as of Q2 2023.

  • Franklin Resources reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Franklin Resources sold 336,358 DICE Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $9.6M.
  • Franklin Resources first reported a position in DICE Therapeutics, Inc. Common Stock in Q4 2022 and held it in 2 quarters.
  • Franklin Resources's DICE Therapeutics, Inc. Common Stock position peaked at $10.5M in Q4 2022.
  • 160 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Franklin Resources's 13F filing for Q2 2023, filed 11 Aug 2023.